Maryam Bashiri1, L John Greenfield2, Alison Oliveto3. 1. 1 Interdisciplinary Biomedical Sciences Graduate Program, Clinical and Translational Sciences Track, University of Arkansas for Medical Sciences , Little Rock, Arkansas. 2. 2 Department of Neurology, University of Arkansas for Medical Sciences , Little Rock, Arkansas. 3. 3 Department of Psychiatry, University of Arkansas for Medical Sciences , Little Rock, Arkansas.
Abstract
BACKGROUND: Teleneurology in Arkansas has been used primarily for management of acute stroke with a state-funded hub-and-spoke model allowing physicians at rural hospitals to access vascular neurologists in time to facilitate tissue plasminogen activator administration. Routine neurologic care has been provided only in small pilot studies. We wished to determine patient interest in participating in teleneurology for routine follow-up visits as well as demographic and medical factors associated with interest. MATERIALS AND METHODS: New and established patients of the Neurology Outpatient Clinic at the University of Arkansas for Medical Sciences (UAMS) were surveyed between March 2011 and December 2012 to assess their interest in participating in teleneurology as well as potential factors associated with their interest. RESULTS: Of 1,441 respondents, 52.4% were interested in telemedicine. Of those interested versus uninterested in telemedicine, respectively, 68.9% versus 36.32% traveled more than 1 h to the clinic, 64.7% versus 35.3% had difficulty secondary to neurological conditions, 22.6% versus 6.8% had missed medical appointments due to travel problems, and 43.1% versus 9.4% had travel-imposed financial hardship. CONCLUSIONS: Telemedicine interest for routine follow-up visits was strong among patients at the UAMS Neurology Outpatient Clinic. Factors positively associated with interest included long travel distances, travel expenses, and transportation difficulties. These results suggest that implementing a telemedicine program for follow-up visits would be acceptable to neurology patients for routine ongoing care.
BACKGROUND: Teleneurology in Arkansas has been used primarily for management of acute stroke with a state-funded hub-and-spoke model allowing physicians at rural hospitals to access vascular neurologists in time to facilitate tissue plasminogen activator administration. Routine neurologic care has been provided only in small pilot studies. We wished to determine patient interest in participating in teleneurology for routine follow-up visits as well as demographic and medical factors associated with interest. MATERIALS AND METHODS: New and established patients of the Neurology Outpatient Clinic at the University of Arkansas for Medical Sciences (UAMS) were surveyed between March 2011 and December 2012 to assess their interest in participating in teleneurology as well as potential factors associated with their interest. RESULTS: Of 1,441 respondents, 52.4% were interested in telemedicine. Of those interested versus uninterested in telemedicine, respectively, 68.9% versus 36.32% traveled more than 1 h to the clinic, 64.7% versus 35.3% had difficulty secondary to neurological conditions, 22.6% versus 6.8% had missed medical appointments due to travel problems, and 43.1% versus 9.4% had travel-imposed financial hardship. CONCLUSIONS: Telemedicine interest for routine follow-up visits was strong among patients at the UAMS Neurology Outpatient Clinic. Factors positively associated with interest included long travel distances, travel expenses, and transportation difficulties. These results suggest that implementing a telemedicine program for follow-up visits would be acceptable to neurology patients for routine ongoing care.
Authors: Samantha M R Kling; Jessica J Falco-Walter; Erika A Saliba-Gustafsson; Donn W Garvert; Cati G Brown-Johnson; Rebecca Miller-Kuhlmann; Jonathan G Shaw; Steven M Asch; Laurice Yang; Carl A Gold; Marcy Winget Journal: Neurol Clin Pract Date: 2021-12
Authors: Parul Dayal; Celia H Chang; William S Benko; Brad H Pollock; Stephanie S Crossen; Jamie Kissee; Aaron M Ulmer; Jeffrey S Hoch; Leslie Warner; James P Marcin Journal: JAMA Netw Open Date: 2019-08-02
Authors: Andrew M Wilson; Nasheed I Jamal; Eric M Cheng; Moira Inkelas; Debra Saliba; Andrea Hanssen; Jorge A Torres; Michael K Ong Journal: J Neurol Date: 2019-11-03 Impact factor: 4.849
Authors: Guangxia Meng; Carrie McAiney; Christopher M Perlman; Ian McKillop; Therese Tisseverasinghe; Helen H Chen Journal: BMC Health Serv Res Date: 2022-04-22 Impact factor: 2.908
Authors: Parul Dayal; Celia H Chang; William S Benko; Aaron M Ulmer; Stephanie S Crossen; Brad H Pollock; Jeffrey S Hoch; Jamie L Kissee; Leslie Warner; James P Marcin Journal: Neurol Clin Pract Date: 2019-08